Novo Holdings

San Francisco, California
Firm Location:San Francisco, California • Boston, Massachusetts • Paris, France • Amsterdam, Netherlands • San Francisco Bay Area • Copenhagen, Denmark
Investor Firms That Co-Invest with Novo Holdings
Novo Holdings Team
Photo of Michael Bauer, Partner at Novo Holdings
Michael Bauer
Novo Holdings·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
Photo of Scott Beardsley, Managing Partner at Novo Holdings
Scott Beardsley
Novo Holdings·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Raymond Camahort, Principal at Novo Holdings
Raymond Camahort
Novo Holdings·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed)
Photo of Shawnalea Frazier, Principal at Novo Holdings
Shawnalea Frazier
Novo Holdings·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Kenneth Harrison, Novo Holdings
Kenneth Harrison
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Kuang He, Vice President at Novo Holdings
Kuang He
Novo Holdings·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Paris (France)
Photo of Max Klement, Principal at Novo Holdings
Max Klement
Novo Holdings·Principal
Sweet spot: $500K
Range: $100K - $1M
Investors in Naarden (Netherlands)
Photo of Heather Ludvigsen, Novo Holdings
Heather Ludvigsen
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Joe Markson, Principal at Novo Holdings
Joe Markson
Novo Holdings·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in IoT (Series B), Investors in IoT (Seed), Investors in IoT (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in FinTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in IoT (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in IoT (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in IoT (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in FinTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in IoT (Pre-seed), Investors in FinTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in FinTech (Seed)
Photo of Priyanka Rohatgi, Partner at Novo Holdings
Priyanka Rohatgi
Novo Holdings·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)